At a glance
ClinicalIndex Comparison RecordN/ACompleted· 35 target
Drug / intervention
glargine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Double Blind, Randomized, Parallel, Cross-Over Comparision of Glycemic Control Achieved With Once a Day Insulin Glargine Versus Detemir in Type 2 Diabetes
In Brief
A clinical study evaluating glargine and detemir for Type 2 Diabetes. Completed, enrolled 35 participants across 1 site.
Detailed Summary
The purpose of this study that when studies using our method of dosing adjustments driven by continuous glucose monitoring and because of the less variable glycemic effect of insulin detemir, insulin detemir treated subjects will spend a significantly greater time in the glucose target range than insulin glargine.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes
CountriesUnited States
CollaboratorsNovo Nordisk A/S
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartOct 2006
First PostedApr 2007
Study CompletionMay 2007
TodayJul 2026
First PostedApr 5, 2007
Enrollment StartOct 1, 2006
Study CompletionMay 1, 2007
TodayJul 2, 2026
Posted 19.2 years ago
Interventions
glarginedrug
detemirdrug